EASTBIO CASE PhD: Cannabisin Production in Hemp Suspension Cells

EASTBIO CASE PhD: Cannabisin Production in Hemp Suspension Cells

Research focus and applicant fit

This Edinburgh CASE doctorate asks whether cannabisins, a family of hemp lignanamides, can be produced reproducibly through a plant-cell platform and translated towards industrial manufacture. Cannabisins are not THC, and the project is not a clinical trial or a promise of proven skincare/medical efficacy. Its distinctive training combines plant-cell biology, transcriptomics, analytical chemistry and bioprocess decision-making with Extracellular, a Bristol-based industrial partner.

The saved official lab page lists the exact title and 16 November 2026 deadline, and the saved 2027 directory lists project 200220. The opportunity should be judged against the individual research scope and award conditions. The four-year funding competition is open worldwide through EASTBIO/Edinburgh Doctoral College awards, with no separate EDC application. Euclid closes at midday on 16 November 2026, for 1 October 2027 entry. The project permits references up to two weeks later, while central guidance requires them by 16 November; confirm the applicable exception before relying on it. Discuss the project with Attila Molnar before applying. Main uncertainties are the scientific advance beyond newly published suspension-cell work, the actual CASE placement/IP terms and final international award coverage. Exact official call; Recruitment route; School funding.

Research Problem and Doctoral Work

Whole-plant extraction can vary with season, biological yield and crop-specific regulation. The advertised alternative is a controlled plant-cell process for cannabisins, with candidate material assessed by RNA sequencing and LC-MS/HPLC analytical characterisation, followed by bench-scale partner validation. The project describes suspension-cell platform development, genetic-tool development and regulatory/metabolic investigation, and an iterative link between cellular evidence and process performance. This report retains those work categories without reproducing engineering targets, constructs, elicitation recipes or optimisation instructions. The advertised pilot comparison is with the established hairy-root route; larger-scale commercial success is a research goal, not an existing result. Advertised research and training scope.

The recruit will train in plant tissue/cell biology, transcriptomic discovery, analytical phytochemistry and industrial process design, including an embedded period at Extracellular. A useful thesis must distinguish compound identity and reproducibility from cell biomass, bulk antioxidant measurements and eventual product performance. Evidence of a cellular change alone does not establish a stable manufacturable process or human benefit. Plausible outputs include a characterised platform and defensible assessment of its limits, subject to feasibility; neither an approved cosmetic nor a patent or commercial process is guaranteed.

Cannabisins are non-cannabinoid lignanamides, so treating them as THC/CBD would misidentify the object. The advert's antioxidant/anti-inflammatory description is a research/ingredient rationale, not evidence that this doctorate tests a clinical endpoint. An independent study by Thiry et al., published on 7 October 2026 in Frontiers in Plant Science 17:1923697, reports cannabisin-related lignanamides in hemp suspension-cell cultures with transcriptomic/metabolic associations. Its authors are based in Luxembourg/Belgium, not this supervisor team. This contemporaneous work means the advert's statement that hairy roots are the only useful biotechnology route should not be repeated as a current field-wide fact. The unresolved advance is the robustness, analytical validation, stability and commercial relevance of the proposed platform. The paper does not prove successful industrial economics or invalidate the new PhD call. Current independent primary research.

The broader industrial value is learning to connect biological uncertainty with analytical quality and scale-up constraints. Extracellular's own site describes food, cosmetic and materials applications, not a healthcare drug-development promise. Company claims about demand and readiness are commercial self-descriptions rather than an independently quantified market forecast. Partner market scope.

School, Programme and Field Context

The host and degree-awarding institution is University of Edinburgh, School of Biological Sciences, College of Science and Engineering. Molnar and McCormick sit in the Molecular Plant Sciences/engineering-biology research environment. Extracellular is the industrial collaborator, not a university or second degree awarder. Registration is Biological Sciences with Internship PhD, four years full-time, for 1 October 2027. It is a funded studentship rather than a four-year employee contract; no additional salaried company appointment is advertised. Directly read 2027 degree programme; Relevant plant-science environment; Exact project.

The school's REF 2021 summary reports 94% four-/three-star research,100% four-star research environment, and fifth UK research power in THE's interpretation of REF 2021. This is historical school-level evidence, not a current hemp/industrial-bioprocess ranking or a lab score. EASTBIO provides core and transferable training mainly in years 1–2, with research focus in years 3–4; the displayed 2026/27 events are not the final 2027 timetable. School subject assessment; Training framework.

The programme also makes the first year probationary, with a thesis committee, 10-week and 10-month reports and an oral presentation at the latter review. Annual review is required for progression, followed by a second-year research poster and third-year school-symposium talk; the fourth year culminates in a thesis and viva. Its generic PIPS description must be read alongside the CASE-specific placement exemption below, rather than adding a second compulsory internship. Programme progression requirements.

CASE students undertake a partner placement of 3–18 months, possibly split, that contributes directly to their thesis, and do not undertake a separate PIPS. The project advert's generic three-month placement does not fix the actual CASE length. Obtain the individual plan, including Bristol travel/temporary accommodation, supervision and publication/IP rules. Students requiring a Student visa must study full-time and normally live within commuting distance of the host, with authorised placement exceptions. CASE-specific placement rules; Attendance rules.

Supervisor and Lab Assessment

Attila Molnar, a Senior Lecturer, is the lead contact at attila.molnar@ed.ac.uk; his group studies epigenetics, DNA repair and plant/algal biotechnology. Alistair McCormick's group combines biochemical and physiological reasoning in plants and microalgae. Their complementary engineering-biology work supports training in biological models and evidence-led assessment, but does not itself establish that hemp lines or partner manufacturing capacity are ready for the student. Molnar profile; McCormick group; Shared research context.

Recent important primary papers

These are three different original studies within the last five years, with distinct DOIs. They concern algal models, plant-context interpretation and photosynthetic function; none establishes this hemp project's production platform. Records from 21 October describe an abstract/data-availability reading for Ferenczi, a visit to a 16-page PDF for Přibylová, and full publisher HTML reading for Barrett. The Přibylová item does not establish which pages were actually read. No original paper PDF or body transcript was located in the audited project files. The 22 October recheck below is separate and does not reproduce or upgrade those historical full-text statements.

1. Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii

Aron Ferenczi ; Matthew Fellbaum ; Yen Peng Chew ; Catherine Kidner ; Attila Molnar. Algal Research 84: 103796. DOI 10.1016/j.algal.2024.103796. First online 2024-11-12; issue/publication record 2024-12. No separate issue number or page range is established for this article-number record.

This algal-model comparison supports the value of context-specific validation. It is not evidence of hemp cannabisin production or industrial yield. Molnar is author 5/5 and corresponding author, marked in the institutional record. On 22 October, the university abstract, full author list and bibliographic record were read; the publisher returned 403, and no current full-paper reading is claimed. Bibliographic recheck; Previously cited primary record.

2. DNA methylation can alter CRISPR/Cas9 editing frequency and DNA repair outcome in a target-specific manner

Adéla Přibylová ; Lukáš Fischer ; Douglas E. Pyott ; Andrew Bassett ; Attila Molnar. New Phytologist 235(6): 2285–2299. DOI 10.1111/nph.18212. First online 2022-05-06; issue/publication record 2022-09-01.

This plant-context study supports interpretation of biological background and reproducibility. It is not a cannabisin production mechanism or a manufacturing improvement recipe. Molnar is author 5/5 and corresponding author, confirmed on the paper first page. On 22 October, the repository cover, first-page abstract/authors/correspondence and institutional bibliography were read; the sixteen-page paper was not read in full. Bibliographic recheck; Previously cited primary record.

3. A promiscuous mechanism to phase separate eukaryotic carbon fixation in the green lineage

James Barrett ; Mihris I. S. Naduthodi ; Yuwei Mao ; Clément Dégut ; Sabina Musiał ; Aidan Salter ; Mark C. Leake ; Michael J. Plevin ; Alistair J. McCormick ; James N. Blaza ; Luke C. M. Mackinder. Nature Plants 10(11): 1801–1813. DOI 10.1038/s41477-024-01812-x. First online 2024-10-09; issue/publication record 2024-11. Exact issue day is not supplied in the verified record.

This original photosynthetic-condensate study illustrates integration of molecular and functional evidence. It does not demonstrate hemp manufacture or industrial success. McCormick is author 9/11; the contribution statement identifies plant-study design/execution and manuscript contributions. Luke C. M. Mackinder is corresponding author, not McCormick. On 22 October, the publisher abstract, ordered authors, contribution/correspondence and citation/date sections were read; the full article was not re-read. Bibliographic recheck.

The three original articles remain indirect supervisor/lab evidence. The independent 2026 field-background study is not added to the named-supervisor count. Multiple URLs for one article are manifestations of the same study, not independent replications.

These three papers establish relevant capabilities indirectly; none is a published result from this exact hemp CASE project. The closer 2026 suspension-cell paper is independent of the team. Ask about unpublished project pilots, who provides daily analytical/bioprocess support, supervisor meeting frequency and current capacity. Extracellular describes itself as a CDMO with plant/animal-cell projects and reports 1–2000 L capability, 35+ projects, 20+ customers and 9,000 ft² facilities. Those are company-reported capabilities, not independently audited utilisation or a student's guaranteed allocation. The advertised work remains bench-stage validation. Partner role and Bristol base; Company-reported infrastructure.

Funding, Application, and Living Cost

Award and CASE agreement

The advert describes a fully funded four-year competition, open worldwide, considering both EASTBIO BBSRC Doctoral Landscape Award and Edinburgh Doctoral College Award, with no separate EDC application. Successful students enter the same cohort. The saved EASTBIO policy says international awardees do not pay the overseas fee top-up; the 30% international intake cap is a funding quota, not an individual probability. Chinese applicants are not excluded by nationality. The exact award route and four-year overseas tuition terms must appear in the award letter; the UKRI cap cannot automatically be assigned to university-funded EDC places. International eligibility and waiver; School award routes.

UKRI's confirmed 2026/27 stipend is £21,805, or £1,817.08/month; 2027/28 is unconfirmed. The school says EDC covers tuition/four-year stipend and a project grant of £5,000/year in years 1–3 and £1,000 in year 4. Research budgets are not personal income, and a company contribution is not an automatic stipend enhancement. The current CASE guidance distinguishes standard, match-funded and employee-based part-time routes; the advert does not identify which financial route applies here. Four years of studentship funding does not mean a four-year industrial employment contract. UKRI reference rate; School project budget; August 2026 CASE guidance.

The CASE partner must cover placement research costs, while support for the student's travel and accommodation is encouraged rather than guaranteed in the August 2026 guidance. Read the signed collaboration/placement agreement for intellectual property, publication review, confidentiality, expenses and contingency if the partner changes plans. EASTBIO excludes visa/IHS; EDC or company reimbursement is unconfirmed. The CASE label alone does not guarantee ring-fenced funding or employment. Current partner obligations; Student agreement responsibilities.

Application and English

Apply through Euclid to Biological Sciences with Internship, selecting 1 October 2027 as the start date. The project gives midday on Monday 16 November 2026 as the application deadline. If this means UK local time, it corresponds to 20:00 China Standard Time; confirm the portal's actual deadline timezone. The project permits references up to two weeks after the closing date, but central guidance explicitly requires them by 16 November. Submit them early where possible and obtain confirmation of any project-specific extension and its final clock. A reference exception does not extend the main application deadline.

Enter the exact project title, proposed supervisors and EASTBIO/Edinburgh Doctoral College Award as the anticipated funding source. Upload the completed EASTBIO application form in the Research Proposal Section. Prepare two references on the official EASTBIO template, from academic or professional referees; references from the proposed project supervisor(s) are not accepted. Supply referee details or completed template letters as instructed; an automatic upload link does not remove the template requirement. Complete the anonymous EDI survey and copy its unique response ID onto the application form. Only one EASTBIO project may be selected across the partnership, regardless of host institution. Include academic transcripts and certified translations of non-English qualifications/documents where required. The section label does not itself establish a requirement for an additional independent research proposal. EASTBIO’s FAQ says additional documents, such as a CV, are disregarded in assessment; this is not a statement that an extra upload automatically invalidates the application. Follow the project and Euclid attachment list.

Applications remain under consideration during shortlisting until 22 February 2027; this is not an extension of the submission deadline. Check Euclid and email for missing-document requests. The university reserves the right to amend or withdraw advertised scholarships. Central mandatory documents; Selection process; Programme application requirements.

The published 2027/28 entry requirements are a relevant UK 2:1 honours degree or international equivalent, some research experience and an understanding of the proposed field. Relevant industrial experience may contribute; non-standard backgrounds are considered individually. No prior mastery of every advertised laboratory method is stated. There is no programme application fee. Individual Chinese-degree equivalence and any ATAS requirement still need confirmation.

The programme lists these English-test routes. The dates in the TOEFL rows refer to when the test was taken, not the application date.

Test	Overall minimum	Component minimum / restriction
IELTS Academic	6.5	6.0 each; One Skill Retake not accepted
TOEFL-iBT, including Home Edition, before 21 January 2026	92	23 each; MyBest not accepted
TOEFL-iBT, including Home Edition, from 21 January 2026	4.5	4.5 each; MyBest not accepted
C1 Advanced (CAE) / C2 Proficiency (CPE)	176	169 each
Oxford ELLT	7	6 each; ELLT Skill Retake not accepted
Oxford Test of English Advanced	145	135 each

IELTS Academic, TOEFL-iBT, Oxford ELLT and Oxford Test of English Advanced must be no more than two years old on the first day of the month in which the programme starts. The other listed tests may be no more than three and a half years old at that point. An English-taught and assessed undergraduate or postgraduate degree can be accepted when awarded in a UKVI-defined majority-English-speaking country, or at an institution on the university's approved list in a non-majority-English-speaking country. For applicants who are not nationals of a majority-English-speaking country, that degree must be no more than five years old on the same reference date; the stated nationality exception removes this degree-age limit, not all language conditions. Do not assume that any English-medium degree in China qualifies. The timing for uploading English evidence should be confirmed with EASTBIO/Euclid; no unverified later deadline is supplied here. Published 2027 entry and English requirements.

Living budget

Edinburgh's 2026/27 postgraduate cost estimate, calculated in March 2026, is £1,542 per month or £18,504 per year: housing/utilities £978, food/shopping £248, phone £12, social/leisure/wellbeing £246 and bus travel £58 for age 22+. The quoted housing/utilities range is £752–£1,249 per month. These are dated cost references, not 2027 housing quotes. The 2027/28 stipend and individual award terms remain unconfirmed, so no stipend-minus-budget balance, disposable-income estimate or savings projection is presented. A Bristol placement may add temporary housing and travel costs unless the signed agreement covers them. University cost estimates and their date.

The saved October 2026 Student visa fee is £558 and IHS £776/year. A conditional 4.5-charge-year example totals £4,050 upfront, excluding flights/deposits; actual CAS and future fees determine the bill. Outside-London maintenance proof is £10,539 for at most nine months, not a full-year Edinburgh budget. Confirm award sponsorship evidence individually. Visa fee; IHS; Maintenance evidence.

Applicant Fit and Preparation

The strongest relevant preparation combines plant/cell biology or biotechnology with quantitative interpretation and interest in industrial constraints. Analytical chemistry, transcriptomic analysis or process engineering can be useful complementary experience, but these are analyst suggestions, not extra universal prerequisites. The advert promises training across the different areas. Applicants seeking a purely computational PhD or a human efficacy trial should clarify the substantial cell-based and process-development scope.

For supervisor contact, prepare a concise discussion of compound identification, replication and the difference between a promising laboratory result and a viable ingredient process. Read the independent 2026 suspension-cell work and ask what new research question remains. Evidence of data quality, statistics and reproducible analysis is useful without submitting a construction plan or pretending to know the unpublished platform. No clinical benefit, company job or guaranteed commercial product follows from the title.

Career value

Transferable career assets include data analysis, plant-cell/analytical research, quality documentation and process interpretation. National Careers Service biological-scientist roles span research and industry; its £28,000–£53,000 starter-to-experienced range is broad occupational context, not this student's outcome. Career evidence.

Next Actions and Questions to Verify

Before applying

Contact Molnar to confirm the current availability of the recorded 2027 project and its difference from earlier recruitment and the new independent 2026 paper. Ask which platform components already exist, what analytical/bioprocess backgrounds are expected versus taught, and the current international fee/CASE route. Confirm personal degree/English conditions and the Euclid/reference timing; complete EDI and select one project.

At interview

Discuss how chemical identity, cell-line stability, reproducibility and process feasibility will be assessed without conflating biomass or generic antioxidant signals with specific product performance. Clarify access to analytical instruments/partner facilities, daily support, supervisor capacity and fallback scientific scope. Agree CASE duration, location and how thesis/IP/publication needs interact with commercial confidentiality.

Before accepting

Obtain final 2027/28 stipend, four-year international tuition coverage, research allocation and the signed CASE/placement agreement. Confirm travel/temporary housing support, immigration costs and contingency if partner capacity changes. Check ATAS/CAS, housing and relocation cash, local progression/ethics governance and the final training timetable.

Evidence and Sources

The recruitment, funding and application evidence was checked on 21 October 2026; the 22 October work reviewed publication metadata and reading boundaries. Institutional pages could not be reopened in that saved consistency check, so it does not reconfirm every recruitment condition. The previous paper-reading descriptions and missing original-paper archives remain distinct from the later abstract, first-page and selected-record checks. The independent October 2026 suspension-cell study is field context, not a supervisor output or proof of industrial viability. Current vacancy, personal award, partner allocation and later versions have not been newly verified.

Project, school and training

• EASTBIO current official application and delegated project directory
• EASTBIO selection and timeline
• EASTBIO training structure
• Edinburgh Biological Sciences REF 2021 subject context
• Biological Sciences with Internship saved 2027 programme
• Exact cannabisin current official doctoral call
• Molecular Plant Sciences green-factory research environment
• Current EASTBIO CASE placement rules
• EASTBIO CASE Guidance August 2026

Supervisors, papers and industry partner

• Attila Molnar official lab profile
• McCormick plant engineering biology lab
• Extracellular industrial partner scope and location
• Extracellular facilities and company-reported scale
• Thiry et al. 2026 cannabisin suspension-cell primary research
• Ferenczi et al. 2024 algal editing comparison
• Pribylova et al. 2022 plant DNA methylation and repair context
• Barrett et al. 2024 cross-lineage pyrenoid biophysics
• Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii — bibliographic recheck address
• DNA methylation can alter CRISPR/Cas9 editing frequency and DNA repair outcome in a target-specific manner — bibliographic recheck address

Funding, living costs and careers

• EASTBIO current eligibility and overseas fee waiver
• SBS 2027 current EASTBIO and EDC funding
• Edinburgh postgraduate living costs 2026/27
• UKRI current stipend and fee minima
• UK Student visa current application fee
• UK student health surcharge
• UK outside-London maintenance evidence
• National Careers Service biological scientist careers